Eliminating viral hepatitis C in Belgium: the micro-elimination approach

Dana Busschots, Samira Toghanian, Rob Bielen, Stina Salomonsson, Ozguer M. Koc, Greet Hendrickx, Michel Jadoul, Frederik Nevens, Etienne Sokal, Christian Brixko, Kathelijne Peerlinck, Ludwig Apers, Geert Robaeys, Jeffrey V. Lazarus*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number181
Number of pages12
JournalBMC Infectious Diseases
Volume20
Issue number1
DOIs
Publication statusPublished - 27 Feb 2020

Keywords

  • Disease elimination
  • Health policy
  • Hepatitis C
  • Treatment
  • Belgium
  • SOFOSBUVIR PLUS RIBAVIRIN
  • VIRUS HCV INFECTION
  • HIV-POSITIVE MSM
  • LIVER-DISEASE
  • INJECT DRUGS
  • PREEXPOSURE PROPHYLAXIS
  • TRANSMISSION
  • PEOPLE
  • BURDEN
  • HEMODIALYSIS

Cite this

Busschots, D., Toghanian, S., Bielen, R., Salomonsson, S., Koc, O. M., Hendrickx, G., Jadoul, M., Nevens, F., Sokal, E., Brixko, C., Peerlinck, K., Apers, L., Robaeys, G., & Lazarus, J. V. (2020). Eliminating viral hepatitis C in Belgium: the micro-elimination approach. BMC Infectious Diseases, 20(1), [181]. https://doi.org/10.1186/s12879-020-4898-y